The Food and Drug Administration gave Pfizer’s two-dose COVID-19 vaccine for people age 16 or older full approval this week. A first in the United States, this decision prompted several schools and businesses to issue vaccine mandates as COVID-19 cases and hospitalizations rise nationwide. It also raises new questions about what this change means for the agency’s emergency use authorizations for other vaccines, as well as for Pfizer boosters and initial doses for adolescents. Dr. Jesse Goodman, a professor of infectious diseases and former chief scientist for the FDA, will join PBS NewsHour correspondent William Brangham to answer these questions and any questions you may have during a live conversation this Friday, Aug. 27 at 1 p.m. ET.
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6
Follow us:
Facebook: http://www.pbs.org/newshour
Twitter: http://www.twitter.com/newshour
Instagram: http://www.instagram.com/newshour
Subscribe:
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts
Newsletters: https://www.pbs.org/newshour/subscribe
